Table 1.
Clinical stage | Age | MeCP2 Mutation | RARS1 scores | Level of2 severity | VABS3 scores |
---|---|---|---|---|---|
II | 4 | R306C | 66.5 | Moderate | 83 |
II | 4 | R255X | 80.5 | severe | 40 |
II | 4 | PT158M | 52.5 | Moderate | 60 |
II | 4 | R306C | 74 | Moderate | 50 |
II | 4 | / | 71.5 | Moderate | 56 |
III | 5 | R294X | 66.5 | Moderate | 80 |
III | 5 | P322A | 58.5 | Moderate | 75 |
III | 7 | / | 47.5 | Moderate | 60 |
III | 7 | R168X | 51.5 | Moderate | 82 |
III | 8 | / | 48.5 | Mild | 121 |
III | 8 | R133C | 35 | Mild | 140 |
III | 10 | FOXG1 | 86.5 | severe | 35 |
III | 10 | T158M | 81 | Severe | 33 |
III | 11 | R255X | 66 | Moderate | 83 |
III | 12 | R306C | 69 | Moderate | 88 |
III | 12 | R306C | 59 | Moderate | 84 |
III | 13 | S355fsX37 | 63.50 | Moderate | 110 |
III | 14 | / | 56 | Moderate | 58 |
III | 14 | R270X | 61.5 | Moderate | 76 |
III | 14 | P322A | 52.5 | Moderate | 86 |
III | 16 | T158M | 71 | Moderate | 92 |
III | 16 | 168RX | 62 | Moderate | 131 |
III | 16 | R133C | 64.5 | Moderate | 110 |
III | 17 | arg168stop | 37 | Mild | 121 |
III | 18 | / | 67.5 | Moderate | 107 |
III | 19 | R255C | 74.5 | Moderate | 84 |
III | 20 | CDLK5 | 61 | Moderate | 56 |
III | 20 | P322L | 58.7 | Moderate | 105 |
III | 22 | P389X | 66.5 | Moderate | 84 |
III | 26 | R270X | 56.5 | Moderate | 65 |
IV | 29 | R255C | 72 | Moderate | 86 |
IV | 29 | R135C | 39 | Mild | 168 |
IV | 31 | R255C | 59.5 | Moderate | 165 |
IV | 35 | / | 47 | Mild | 118 |
IV | 36 | T158M | 59 | Moderate | 63 |
1Rett Assessment Rating Scales (RARS)
2Levels of severity according to the total scores of RARS (Mild = 0–55; Moderate = 56–81; Severe= > 81)
3Vineland Adaptive Behaviour Scales-Interview second edition (VABS)